作者
- Armstrong, P.W. (140)
- Califf, R.M. (44)
- Granger, C.B. (53)
- Harrington, R.A. (25)
- Mahaffey, K.W. (21)
- Ohman, E.M. (19)
- Simoons, M.L. (16)
- Van de Werf, F. (35)
- Westerhout, C.M. (21)
- White, H.D. (21)
|
總筆數:140
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Randomized evaluation of the efficacy of enoxaparin versusunfractionated heparin in high-risk patients with non-ST-segment elevationacute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitoreptifibatide. Long-term results of the Integrilin and Enoxaparin RandomizedAssessment of Acute Coronary Syndrome Treatment (INTERACT) trial |
for the INTERACT Trial Long-Term Follow-Up Investigators;Fitchett, D.H.;Langer, A.;Armstrong, P.W.;Tan, M.;Mendelsohn, A.;Goodman, S.G.; |
American Heart Journal |
2006-02-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| What is the frequency and functional and clinical significance ofcomplex lesions in non-infarct-related arteries after fibrinolysis foracute ST-elevation myocardial infarction? |
for the CAPTORS II Investigators;Kim, D.H.;Burton, J.R.;Fu, Y.;Lindholm, L.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2006-03-01 |
查看 |
| Concerning the mechanism of pexelizumab's benefit in acute myocardialinfarction |
COMMA Investigators;Armstrong, P.W.;Mahaffey, K.W.;Chang, W.C.;Weaver, W.D.;Hochman, J.S.;Theroux, P.;Rollins, S.;Todaro, T.G.;Granger, C.B.; |
American Heart Journal |
2006-04-01 |
查看 |
| Concerning the mechanism of pexelizumab's benefit in acute myocardialinfarction |
COMMA Investigators;Armstrong, P.W.;Mahaffey, K.W.;Chang, W.C.;Weaver, W.D.;Hochman, J.S.;Theroux, P.;Rollins, S.;Todaro, T.G.;Granger, C.B.; |
American Heart Journal |
2006-04-01 |
查看 |
| The prognostic value of the admission and predischargeelectrocardiogram in acute coronary syndromes: The GUSTO-IIb ECG CoreLaboratory experience |
for the GUSTO-IIb Investigators;Goodman, S.G.;Fu, Y.;Langer, A.;Barr, A.;Tan, M.;Wagner, G.S.;Barbagelata, A.;Sgarbossa, E.B.;Birnbaum, Y.;Granger, C.B.;Califf, R.M.;Van de Werf, F.;Topol, E.J.;Armstrong, P.W.; |
American Heart Journal |
2006-08-01 |
查看 |
| Effect of pexelizumab on mortality in patients with acute myocardialinfarction or undergoing coronary artery bypass surgery: A systematicoverview |
Mahaffey, K.W.;Van de Werf, F.;Shernan, S.K.;Granger, C.B.;Verrier, E.D.;Filloon, T.G.;Todaro, T.G.;Adams, P.X.;Levy, J.H.;Hasselblad, V.;Armstrong, P.W.; |
American Heart Journal |
2006-08-01 |
查看 |
| The prognostic value of the admission and predischargeelectrocardiogram in acute coronary syndromes: The GUSTO-IIb ECG CoreLaboratory experience |
for the GUSTO-IIb Investigators;Goodman, S.G.;Fu, Y.;Langer, A.;Barr, A.;Tan, M.;Wagner, G.S.;Barbagelata, A.;Sgarbossa, E.B.;Birnbaum, Y.;Granger, C.B.;Califf, R.M.;Van de Werf, F.;Topol, E.J.;Armstrong, P.W.; |
American Heart Journal |
2006-08-01 |
查看 |
| Effect of pexelizumab on mortality in patients with acute myocardialinfarction or undergoing coronary artery bypass surgery: A systematicoverview |
Mahaffey, K.W.;Van de Werf, F.;Shernan, S.K.;Granger, C.B.;Verrier, E.D.;Filloon, T.G.;Todaro, T.G.;Adams, P.X.;Levy, J.H.;Hasselblad, V.;Armstrong, P.W.; |
American Heart Journal |
2006-08-01 |
查看 |
| Reflections on early stopping of a clinical trial |
Armstrong, P.W.;Granger, C.B.; |
American Heart Journal |
2006-09-01 |
查看 |
| Reflections on early stopping of a clinical trial |
Armstrong, P.W.;Granger, C.B.; |
American Heart Journal |
2006-09-01 |
查看 |
| Reflections on early stopping of a clinical trial |
Armstrong, P.W.;Granger, C.B.; |
American Heart Journal |
2006-09-01 |
查看 |
| Age, outcomes, and treatment effects of fibrinolytic and antithromboticcombinations: Findings from Assessment of the Safety and Efficacy of a NewThrombolytic (ASSENT)-3 and ASSENT-3 PLUS |
on behalf of the ASSENT-3 and ASSENT-3 PLUS investigators;Sinnaeve, P.R.;Huang, Y.;Bogaerts, K.;Vahanian, A.;Adgey, J.;Armstrong, P.W.;Wallentin, L.;Van de Werf, F.J.;Granger, C.B.; |
American Heart Journal |
2006-10-01 |
查看 |
| Age, outcomes, and treatment effects of fibrinolytic and antithromboticcombinations: Findings from Assessment of the Safety and Efficacy of a NewThrombolytic (ASSENT)-3 and ASSENT-3 PLUS |
on behalf of the ASSENT-3 and ASSENT-3 PLUS investigators;Sinnaeve, P.R.;Huang, Y.;Bogaerts, K.;Vahanian, A.;Adgey, J.;Armstrong, P.W.;Wallentin, L.;Van de Werf, F.J.;Granger, C.B.; |
American Heart Journal |
2006-10-01 |
查看 |
| Feasibility and applicability of paramedic-based prehospitalfibrinolysis in a large North American center |
Welsh, R.C.;Travers, A.;Senaratne, M.;Williams, R.;Armstrong, P.W.; |
American Heart Journal |
2006-12-01 |
查看 |
| Feasibility and applicability of paramedic-based prehospitalfibrinolysis in a large North American center |
Welsh, R.C.;Travers, A.;Senaratne, M.;Williams, R.;Armstrong, P.W.; |
American Heart Journal |
2006-12-01 |
查看 |
| Feasibility and applicability of paramedic-based prehospitalfibrinolysis in a large North American center |
Welsh, R.C.;Travers, A.;Senaratne, M.;Williams, R.;Armstrong, P.W.; |
American Heart Journal |
2006-12-01 |
查看 |
| No prognostic significance of chronic infection with Chlamydiapneumoniae in acute coronary syndromes: Insights from the GlobalUtilization of Strategies to Open Occluded Arteries IV Acute CoronarySyndromes trial |
on behalf of the GUSTO IV ACS Investigators;Westerhout, C.M.;Gnarpe, J.;Chang, W.C.;FitzPatrick, S.;Barnathan, E.S.;Boersma, E.;Califf, R.M.;Wallentin, L.;Simoons, M.L.;Armstrong, P.W.; |
American Heart Journal |
2007-08-01 |
查看 |
| Use of evidence-based medicine for acute coronary syndromes in theelderly and very elderly: Insights from the Sibrafiban vs aspirin to YieldMaximum Protection from ischemic Heart events postacute cOroNary sYndromestrials |
for the SYMPHONY and 2nd SYMPHONY Investigators;Wong, C.K.;Newby, L.K.;Bhapker, M.V.;Aylward, P.E.;Pfisterer, M.;Alexander, K.P.;Armstrong, P.W.;Hochman, J.S.;Van de Werf, F.;Califf, R.M.;White, H.D.; |
American Heart Journal |
2007-08-01 |
查看 |
| No prognostic significance of chronic infection with Chlamydiapneumoniae in acute coronary syndromes: Insights from the GlobalUtilization of Strategies to Open Occluded Arteries IV Acute CoronarySyndromes trial |
on behalf of the GUSTO IV ACS Investigators;Westerhout, C.M.;Gnarpe, J.;Chang, W.C.;FitzPatrick, S.;Barnathan, E.S.;Boersma, E.;Califf, R.M.;Wallentin, L.;Simoons, M.L.;Armstrong, P.W.; |
American Heart Journal |
2007-08-01 |
查看 |
| Use of evidence-based medicine for acute coronary syndromes in theelderly and very elderly: Insights from the Sibrafiban vs aspirin to YieldMaximum Protection from ischemic Heart events postacute cOroNary sYndromestrials |
for the SYMPHONY and 2nd SYMPHONY Investigators;Wong, C.K.;Newby, L.K.;Bhapker, M.V.;Aylward, P.E.;Pfisterer, M.;Alexander, K.P.;Armstrong, P.W.;Hochman, J.S.;Van de Werf, F.;Califf, R.M.;White, H.D.; |
American Heart Journal |
2007-08-01 |
查看 |
| Guideline adjudicated fibrinolytic failure: Incidence, findings, andmanagement in a contemporary clinical trial |
Buller, C.E.;Welsh, R.C.;Westerhout, C.M.;Webb, J.G.;O'Neill, B.;Gallo, R.;Armstrong, P.W.; |
American Heart Journal |
2008-01-01 |
查看 |
| Guideline adjudicated fibrinolytic failure: Incidence, findings, andmanagement in a contemporary clinical trial |
Buller, C.E.;Welsh, R.C.;Westerhout, C.M.;Webb, J.G.;O'Neill, B.;Gallo, R.;Armstrong, P.W.; |
American Heart Journal |
2008-01-01 |
查看 |
| Association between bleeding, blood transfusion, and costs amongpatients with non-ST-segment elevation acute coronary syndromes |
Rao, S.V.;Kaul, P.R.;Liao, L.;Armstrong, P.W.;Ohman, E.M.;Granger, C.B.;Califf, R.M.;Harrington, R.A.;Eisenstein, E.L.;Mark, D.B.; |
American Heart Journal |
2008-02-01 |
查看 |
| Association between bleeding, blood transfusion, and costs amongpatients with non-ST-segment elevation acute coronary syndromes |
Rao, S.V.;Kaul, P.R.;Liao, L.;Armstrong, P.W.;Ohman, E.M.;Granger, C.B.;Califf, R.M.;Harrington, R.A.;Eisenstein, E.L.;Mark, D.B.; |
American Heart Journal |
2008-02-01 |
查看 |
| Noninvasive, medical management for non-ST-elevation acute coronarysyndromes |
Chan, M.Y.;Becker, R.C.;Harrington, R.A.;Peterson, E.D.;Armstrong, P.W.;White, H.;Fox, K.A.A.;Ohman, E.M.;Roe, M.T.; |
American Heart Journal |
2008-03-01 |
查看 |
| Contribution of angiographic and electrocardiographic parameters ofreperfusion to prediction of mortality and morbidity after acuteST-elevation myocardial infarction: Insights from the Assessment ofPexelizumab in Acute Myocardial Infarction trial |
for the APEX-AMI Investigators;Brener, S.J.;Westerhout, C.M.;Fu, Y.;Todaro, T.G.;Moliterno, D.J.;Wagner, G.S.;Granger, C.B.;Armstrong, P.W.; |
American Heart Journal |
2009-11-01 |
查看 |
| Safety and feasibility of adjunctive antiplatelet therapy withintravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptorantagonist, before primary percutaneous intervention in patients withST-elevation myocardial infarction: The Early Rapid ReversAl of PlateletThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion inAcute Myocardial Infarction (ERASE MI) pilot trial |
Berger, J.S.;Roe, M.T.;Gibson, C.M.;Kilaru, R.;Green, C.L.;Melton, L.;Blankenship, J.D.;Metzger, D.C.;Granger, C.B.;Gretler, D.D.;Grines, C.L.;Huber, K.;Zeymer, U.;Buszman, P.;Harrington, R.A.;Armstrong, P.W.; |
American Heart Journal |
2009-12-01 |
查看 |
| Plasma N-terminal fragment of the prohormone B-type natriuretic peptideconcentrations in relation to time to treatment and Thrombolysis inMyocardial Infarction (TIMI) flow: A substudy of the Assessment of theSafety and Efficacy of a New Treatment Strategy with Percutaneous CoronaryIntervention (ASSENT IV-PCI) trial |
on behalf of the ASSENT IV-PCI investigators;Jarai, R.;Huber, K.;Bogaerts, K.;Droogne, W.;Ezekowitz, J.;Granger, C.B.;Sinnaeve, P.R.;Ross, A.M.;Zeymer, U.;Armstrong, P.W.;Van de Werf, F.J.; |
American Heart Journal |
2010-01-01 |
查看 |
| Is visual interpretation of coronary epicardial flow reliable inpatients with ST-elevation myocardial infarction undergoing primaryangioplasty? Insights from the angiographic substudy of the Assessment ofPexelizumab in Acute Myocardial Infarction (APEX-AMI) trial |
for the APEX AMI Investigators;Alhadramy, O.;Westerhout, C.M.;Brener, S.J.;Granger, C.B.;Armstrong, P.W.; |
American Heart Journal |
2010-05-01 |
查看 |
| ST2 and mortality in non@?ST-segment elevation acute coronary syndrome |
Eggers, K.M.;Armstrong, P.W.;Califf, R.M.;Simoons, M.L.;Venge, P.;Wallentin, L.;James, S.K.; |
American Heart Journal |
2010-05-01 |
查看 |
| ST2 and mortality in non@?ST-segment elevation acute coronary syndrome |
Eggers, K.M.;Armstrong, P.W.;Califf, R.M.;Simoons, M.L.;Venge, P.;Wallentin, L.;James, S.K.; |
American Heart Journal |
2010-05-01 |
查看 |
| Is visual interpretation of coronary epicardial flow reliable inpatients with ST-elevation myocardial infarction undergoing primaryangioplasty? Insights from the angiographic substudy of the Assessment ofPexelizumab in Acute Myocardial Infarction (APEX-AMI) trial |
for the APEX AMI Investigators;Alhadramy, O.;Westerhout, C.M.;Brener, S.J.;Granger, C.B.;Armstrong, P.W.; |
American Heart Journal |
2010-05-01 |
查看 |
| Unexplained international differences in clinical outcomes after acutemyocardial infarction and fibrinolytic therapy: Lessons from the Hirulogand Early Reperfusion or Occlusion (HERO)-2 trial |
for the HERO-2 Investigators;Simes, R.J.;O'Connell, R.L.;Aylward, P.E.;Varshavsky, S.;Diaz, R.;Wilcox, R.G.;Armstrong, P.W.;Granger, C.B.;French, J.K.;Van de Werf, F.;Marschner, I.C.;Califf, R.;White, H.D.; |
American Heart Journal |
2010-06-01 |
查看 |
| Study design and rationale of a comparison of prasugrel and clopidogrelin medically managed patients with unstable angina/non-ST-segment elevationmyocardial infarction: The TaRgeted platelet Inhibition to cLarify theOptimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS)trial |
on behalf of the TRILOGY ACS Steering Committee;Chin, C.T.;Roe, M.T.;Fox, K.A.A.;Prabhakaran, D.;Marshall, D.A.;Petitjean, H.;Lokhnygina, Y.;Brown, E.;Armstrong, P.W.;White, H.D.;Ohman, E.M.; |
American Heart Journal |
2010-07-01 |
查看 |
| The Strategic Reperfusion Early After Myocardial Infarction (STREAM)study |
on behalf of the STREAM Steering Committee;Armstrong, P.W.;Gershlick, A.;Goldstein, P.;Wilcox, R.;Danays, T.;Bluhmki, E.;Van de Werf, F.; |
American Heart Journal |
2010-07-01 |
查看 |
| Predicting chronic left ventricular dysfunction 90 days afterST-segment elevation myocardial infarction: An Assessment of Pexelizumab inAcute Myocardial Infarction (APEX-AMI) Substudy |
Ezekowitz, J.A.;Armstrong, P.W.;Granger, C.B.;Theroux, P.;Stebbins, A.;Kim, R.J.;Patel, M.R.; |
American Heart Journal |
2010-08-01 |
查看 |
| Does silent myocardial infarction add prognostic value in ST-elevationmyocardial infarction patients without a history of prior myocardialinfarction? Insights from the Assessment of Pexelizumab in Acute MyocardialInfarction (APEX-AMI) Trial |
Toma, M.;Fu, Y.;Ezekowitz, J.A.;McAlister, F.A.;Westerhout, C.M.;Granger, C.B.;Armstrong, P.W.; |
American Heart Journal |
2010-10-01 |
查看 |
| Does silent myocardial infarction add prognostic value in ST-elevationmyocardial infarction patients without a history of prior myocardialinfarction? Insights from the Assessment of Pexelizumab in Acute MyocardialInfarction (APEX-AMI) Trial |
Toma, M.;Fu, Y.;Ezekowitz, J.A.;McAlister, F.A.;Westerhout, C.M.;Granger, C.B.;Armstrong, P.W.; |
American Heart Journal |
2010-10-01 |
查看 |
| Temporal trends in patient and treatment delay among men and womenpresenting with ST-elevation myocardial infarction |
Kaul, P.;Armstrong, P.W.;Sookram, S.;Leung, B.K.;Brass, N.;Welsh, R.C.; |
American Heart Journal |
2011-01-01 |
查看 |
| The influence of time from symptom onset and reperfusion strategy on1-year survival in ST-elevation myocardial infarction: A pooled analysis ofan early fibrinolytic strategy versus primary percutaneous coronaryintervention from CAPTIM and WEST |
Westerhout, C.M.;Bonnefoy, E.;Welsh, R.C.;Steg, P.G.;Boutitie, F.;Armstrong, P.W.; |
American Heart Journal |
2011-02-01 |
查看 |
| Relationship of sustained ventricular tachyarrhythmias to outcomes inpatients undergoing primary percutaneous coronary intervention with varyingunderlying baseline risk |
Mehta, R.H.;Starr, A.Z.;Lopes, R.D.;Piccini, J.P.;Patel, M.R.;Pieper, K.S.;Armstrong, P.W.;Granger, C.B.; |
American Heart Journal |
2011-04-01 |
查看 |
| Refining clinical trial composite outcomes: An application to theAssessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3)trial |
Armstrong, P.W.;Westerhout, C.M.;Van de Werf, F.;Califf, R.M.;Welsh, R.C.;Wilcox, R.G.;Bakal, J.A.; |
American Heart Journal |
2011-05-01 |
查看 |
| Cardiogenic shock and heart failure post-percutaneous coronaryintervention in ST-elevation myocardial infarction: Observations from''Assessment of Pexelizumab in Acute Myocardial Infarction'' |
French, J.K.;Armstrong, P.W.;Cohen, E.;Kleiman, N.S.;O'Connor, C.M.;Hellkamp, A.S.;Stebbins, A.;Holmes, D.R.;Hochman, J.S.;Granger, C.B.;Mahaffey, K.W.; |
American Heart Journal |
2011-07-01 |
查看 |
| Mode of hospital presentation in patients with non-ST-elevationmyocardial infarction: Implications for strategic management |
Tymchak, W.;Armstrong, P.W.;Westerhout, C.M.;Sookram, S.;Brass, N.;Fu, Y.;Welsh, R.C.; |
American Heart Journal |
2011-09-01 |
查看 |
| Safety and efficacy of adjusted-dose eptifibatide in patients withacute coronary syndromes and reduced renal function |
Melloni, C.;James, S.K.;White, J.A.;Giugliano, R.P.;Harrington, R.A.;Huber, K.;Tricoci, P.;Armstrong, P.W.;Van de Werf, F.;Montalescot, G.;Califf, R.M.;Newby, L.K.; |
American Heart Journal |
2011-11-01 |
查看 |
| Safety and efficacy of adjusted-dose eptifibatide in patients withacute coronary syndromes and reduced renal function |
Melloni, C.;James, S.K.;White, J.A.;Giugliano, R.P.;Harrington, R.A.;Huber, K.;Tricoci, P.;Armstrong, P.W.;Van de Werf, F.;Montalescot, G.;Califf, R.M.;Newby, L.K.; |
American Heart Journal |
2011-11-01 |
查看 |
| Variations in practice and outcomes in patients undergoing primarypercutaneous coronary intervention in the United States and Canada:Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction(APEX AMI) trial |
Mehta, R.H.;Kaul, P.;Lopes, R.D.;Patel, M.R.;Zheng, Y.;Pieper, K.S.;Welsh, R.C.;Armstrong, P.W.;Granger, C.B.; |
American Heart Journal |
2012-05-01 |
查看 |
| Pexelizumab fails to inhibit assembly of the terminal complementcomplex in patients with ST-elevation myocardial infarction undergoingprimary percutaneous coronary intervention. Insight from a substudy of theAssessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial |
Martel, C.;Granger, C.B.;Ghitescu, M.;Stebbins, A.;Fortier, A.;Armstrong, P.W.;Bonnefoy, A.;Theroux, P.; |
American Heart Journal |
2012-07-01 |
查看 |
| Aborted myocardial infarction after primary percutaneous coronaryintervention: Magnetic resonance imaging insights from the Assessment ofPexelizumab in Acute Myocardial Infarction (APEX-AMI) trial |
Patel, M.R.;Westerhout, C.M.;Granger, C.B.;Brener, S.J.;Fu, Y.;Siha, H.;Kim, R.J.;Armstrong, P.W.; |
American Heart Journal |
2013-02-01 |
查看 |
|
|
|
